Merck was expected to start a phase three trial of its oral PCSK9 drug in the second half of 2023, according to Meg Terrell.
“Merck is expected to start that in the second half of 2023”
Person
Meg Terrell is a host of STAT's podcast The Readout Loud, where she discussed drug approvals, Covid vaccines and boosters, obesity drugs, and cholesterol medicines in episodes from 2021 and 2023. This page collects what she said, each with the exact quote and a link to the moment.
She said an FDA advisory committee voted 19 to 0 in favor of selling Emergent BioSolutions' Narcan nasal spray over the counter. She also said Amgen's injectable PCSK9 drug has passed $1 billion in annual sales, while Regeneron's has not. On boosters, she described the path from FDA advisers to the FDA, the CDC's advisory committee, and the CDC director.
3 episodes · 16 quoted claims
Merck was expected to start a phase three trial of its oral PCSK9 drug in the second half of 2023, according to Meg Terrell.
“Merck is expected to start that in the second half of 2023”
Amgen's injectable PCSK9 drug has passed $1 billion in annual sales, while Regeneron's has not, according to Meg Terrell.
“I mean, the Amgen drug has surpassed $1 billion in annual sales. The Regeneron one hasn't.”
The GLP-1 drugs discussed include Novo Nordisk's Ozempic and Wegovy and Eli Lilly's Mounjaro.
“They are Novo Nordisk's Ozempic and Wagovi and Eli Lilly's Monjaro.”
Moderna CEO Stéphane Bancel agreed to testify at a Senate HELP Committee hearing, led by Bernie Sanders and scheduled for March 22, about the planned Covid vaccine price increase.
“touting that Moderna CEO Stefan Boncel had agreed to appear and testify in a hearing sort of hilariously titled, taxpayers paid billions for it.”
Pfizer CEO Albert Bourla has said that provisions in the Inflation Reduction Act would remove copays for insured people, including for Covid vaccines.
“this is something that Pfizer CEO Albert Bourla has been out there on as well, actually saying that there are provisions in the Inflation Reduction Act that would take away any co-pays that insured people have”
Narcan is the brand name of the nasal spray version of naloxone, an opioid overdose antidote that has existed since the 1970s.
“Narcan is the brand name for the nasal spray version of naloxone, the opioid overdose antidote, this incredible drug that's been around since the 70s”
Emergent BioSolutions, which applied to sell Narcan over the counter, manufactured the J&J and AstraZeneca Covid vaccines during the pandemic and mixed up some of the ingredients.
“This is the company that famously during the pandemic was manufacturing the J &J vaccine and the AstraZeneca vaccine and mixed up some of the ingredients.”
An FDA advisory committee voted 19 to 0 in favor of making Emergent BioSolutions' Narcan nasal spray available over the counter.
“And the committee ended up voting 19 to 0 in favor of turning this over the counter.”
Activist investor Bill Ackman publicly supported Vivek Ramaswamy on Twitter during the week of this episode.
“I think that is a point that was also made by activist investor Bill Ackman, who threw his support behind Vivek on Twitter this week.”
The FDA authorized Pfizer's Covid booster for people six months past their primary series who are 65 or older or at high risk of severe Covid.
“The FDA has authorized Pfizer's booster for people six months out from their primary vaccination, people 65 and older, people who are at high risk of severe outcomes of COVID”
Acting FDA Commissioner Janet Woodcock said the high-exposure group for Pfizer boosters includes teachers, daycare workers, grocery workers, and people in prisons and homeless shelters.
“Dr. Janet Woodcock, the acting FDA commissioner, specified in the FDA's release that includes folks like teachers, daycare workers, grocery store workers, and people who are in prisons and homeless shelters.”
Meg Terrell described the booster approval path as FDA advisers, then the FDA, then the CDC's advisory committee, then CDC director sign-off.
“the FDA has to decide and the CDC's advisory group meets and then the CDC director signs off on it”
Johnson & Johnson released a long press release combining data from several studies, including a second shot given two months later.
“Johnson & Johnson putting like four studies worth of information into one very long press release where they talked about their second shot two months later.”
A study of remdesivir in non-hospitalized patients, given as three days of IV treatment, suggested it could keep people out of the hospital, as monoclonal antibodies can.
“You have to get three days of IV treatment. It suggested that can keep you out of the hospital as potentially as well as monoclonal antibodies.”
STAT polling found that vaccinated Trump voters were much less likely than vaccinated Biden voters to plan to get a booster.
“A lot fewer vaccinated Trump voters plan to get a booster than vaccinated Biden voters.”
Former CDC director Tom Frieden criticized Moderna and Pfizer for not sharing expertise and patents to expand vaccine manufacturing abroad.
“he also is really taking aim at the companies, Moderna and Pfizer in particular, for not sharing their expertise and their patents”